- $92.98m
- $122.63m
- $24.84m
Brief: Janone Inc. Develops Plan For Treating Methamphetamine Use Disorder
Brief: Janone Says Subsidiary Arca Awarded Recycling Contract In Virginia And North Carolina
Brief: Janone Inc Acquires An Option For The Rights To A Worldwide Exclusive License For A Novel Strategy For Treating Methamphetamine Use Disorder
Brief: Arca Recycling, Subsidiary Of Janone, Launches Two Recycling Programs In California In Effort To Reduce GHG Emissions
Brief: ARCA Recycling A Subsidiary Of Janone Inc Sees Major Increase In Appliance Replacement Contracts
Brief: ARCA Recycling, A Subsidiary Of Janone Inc, Awarded Recycling Contracts In Pennsylvania With Total Estimated Value Of $20 Mln
Brief: Janone Says Co Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design Of Lead Drug Candidate JAN101
Brief: Janone Reports U.S. SEC Filed Civil Complaint Naming Janone & One Of Its Executive Officers As Defendants
Brief: Janone Selects CPC Clinical Research As Trial Manager For Phase 2B Study Of Jan101
Brief: Janone Readies Clinical Supply Of Lead Product Candidate Jan101 For Distribution To Phase 2B Trial Sites
Brief: Janone Selects Regulatory Partner For Phase 2B Trial As Investigational Plan Is Prepared For FDA Filing
NASDAQ RESUMED AT 10:09 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:05 AM
NASDAQ RESUMED AT 10:00 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:51 AM
U.S. STOCKS ON THE MOVE-Target, Wendy's, Hyatt Hotels, Sage, crypto stocks
JanOne jumps on progress towards Phase 2 trial